Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,693 | 5,742 | 0 | 0 | 0 |
| Other current assets | 925 | 91 | 0 | 0 | 0 |
| TOTAL | $17,618 | $5,833 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 824 | 0 | 0 | 0 |
| TOTAL | $N/A | $824 | $N/A | $N/A | $N/A |
| Total Assets | $17,618 | $6,657 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,362 | 2,024 | 0 | 0 | 0 |
| Accrued Expenses | 697 | 395 | 0 | 0 | 0 |
| TOTAL | $3,059 | $2,419 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 15,246 | 0 | 0 | 0 |
| TOTAL | $N/A | $15,246 | $N/A | $N/A | $N/A |
| Total Liabilities | $3,059 | $17,665 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,718 | 12,718 | 12,718 | N/A | N/A |
| Retained earnings | -15,843 | -12,900 | 0 | 0 | 0 |
| TOTAL | $14,559 | $-11,008 | $0 | $0 | $0 |
| Total Liabilities And Equity | $17,618 | $6,657 | $0 | $0 | $0 |